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Abstract
Lehoux et al provide a timely and relevant turn on the broad and ongoing discussion around the introduction of health 
technology and innovation. More specifically, the authors suggest a demand-driven approach to health innovation that 
starts from identifying challenges and demands at the health system level. In this commentary, I review a number of 
underlying implications of their study in relation to positions of technology push and techno-optimism, and to the narrow 
focus on health technology assessment on economic and clinical values. While Lehoux et al’s scoping review provides 
very relevant insights with the potential to drive further empirical research, it is less clear about its conceptual basis. In 
particular, the somewhat artificial distinction between health innovations and health systems is worth further scrutiny. I 
discuss some potential risks of this separation, and propose to more openly address the co-constitution of health, health 
systems and technology in future research along the lines suggested by Lehoux et al. 
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Towards Demand-Driven Health Innovations
Lehoux et al1 provide a timely and relevant turn on the broad 
and ongoing discussion around the introduction of new 
health technologies. Most importantly, the paper contributes 
to the literature that has questioned a narrow perspective 
on clinical and economic values in health technology 
assessments, and it re-directs our attention to the broader 
health and innovation systems in which health technologies 
are embedded.2 Considering these systems is, according to 
Lehoux et al,1 pertinent in order to meaningfully implement 
responsible health innovations across a range of contexts, 
including countries with high, medium and low human 
development indices. More specifically, the authors suggest 
a demand-driven approach to health innovation that starts 
from identifying challenges and demands at the health system 
level. This, indeed, is an important complement to the many 
technology push perspectives on health innovation that thrive 
on often unnuanced framings of technological innovations as 
a panacea to societal challenges.3,4
It is particularly valuable that the paper challenges the 
dominant “more is better” approach to new treatments and 
health technologies. Here, often even small improvements of 
patient value are positioned as inherently “good,” although 
they may come with significant side effects, such as increases 
in health inequalities. The authors rightly point to the many 
risks that this perspective implies because its inherent techno-
optimism might gloss over more delicate issues of affordability, 
acceptability and adaptability (p. 65). Indeed, if policy-
makers were to follow suit, and continue to unquestioningly 
tie in health innovations with economic growth and a focus 
on healthcare costs, this implies significant risks that health 
innovations may contribute to the further commodification 
of healthcare and responsibilisation of patients.3,5 Next to the 
ethical questions this brings along, it will also hamper the 
equal distribution of health innovations among those that 
need it. 
To rectify this, Lehoux et al highlight the need to design 
health innovations that purposefully support health systems. 
This is part and parcel of the emerging responsible innovation 
in health approach. However, according to Lehoux et al 
surprisingly little factual knowledge is available about the 
system level challenges that health innovations need to 
address in order to be responsible, and which health system 
challenges may even aggravate as result of health innovations. 
It is this very gap that the scoping review strives to close. If we 
are to direct health innovations into direction that “support 
health systems around the world” (p. 64), then we need to 
have at least a basic understanding of the range and scope of 
innovation challenges faced by health systems worldwide. And 
it is indeed perplexing that, so far, we do not have systematic 
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insights in such challenges beyond more immediate economic 
and clinical values. A scoping review that maps the existing 
literature and takes stock of existing insights about health 
system challenges is highly valuable. 
Dynamizing Health System Challenges and Needs
The scoping review certainly is an important first step in 
grasping the implications of health innovation at the health 
system level. However, in order for such an agenda to thrive, I 
feel that a more explicit conceptualization of the entanglements 
of health innovations and health systems is also required. In 
this regard, I am not convinced that the framing of health 
innovations, on the one hand, and health systems, on the 
other, as two analytically separate and separable entities 
is helpful. At the theoretical level, this separation risks 
reinforcing the technology push logic – which essentially 
assumes technologies to have an “impact,” for better or worth, 
on otherwise independent social contexts6 – that the paper 
strives to eschew. 
Against this background, I would like to highlight a number 
of conceptual issues that subsequent empirical research would 
need to consider in order to embrace the complexities of 
health innovation and its inherent and dynamic entanglement 
with the social and cultural values it is part of. In doing so, I 
draw on insights from Science and Technology Studies (STS), 
a domain that studies the mutual shaping of society and 
technology[1].7
In STS a long-standing discussion concerns the 
“Collingridge” dilemma of innovation and technology 
assessment.9-11 It basically says that that innovation can be 
steered towards desirable directions relatively easily in early 
phases of development, when its consequences are not yet 
known. In later stages of innovations, when the “impact” of 
an innovation is known, influence is much more difficult. 
Against this background, the separation of context from 
innovation that Lehoux et al make seems to place too much 
emphasis on the needs of existing health systems as guidance 
for responsible innovation, where a more careful attention to 
value dynamism might be more appropriate. 
Value dynamism is an issue that has recently been raised 
in the ethics of technology innovation, where scholars 
have begun to discuss that and how values and other 
ethical concerns like trust or privacy are dynamic and 
change alongside with innovations.12,13 For innovations, it 
is inherently problematic, then, to talk about an impact on 
specific aspects of an allegedly surrounding social system, or 
single out specific stable needs in relation to an innovation. 
For instance, Lehoux et al discuss the impact of health 
innovation on human resources. While this is indeed a crucial 
point in extending the existing focus on economic or clinical 
impact, it is also important to recognize how innovations may 
require a whole new range of tasks and job profiles that need 
to be mapped in order to fully understand impact on human 
resources. STS research on the introduction of new care 
technologies, for instance, has shown how the introduction 
of TeleCare systems bring into sight new job profiles, such as 
installers and call center employees.14,15 Lehoux et al do not 
fully exclude such fundamental shifts in health systems from 
their analysis. But in further research it needs to be clarified 
in how far the dynamic and mutually shaping relationships 
between innovations and health systems are taken on board 
conceptually. 
The Co-Constitution of Health Systems and Innovation
Recently, my colleagues and I working on ageing and 
technology have suggested a framework of co-constitution 
for the analysis and practical guidance of gerontechnological 
innovations.4,6 To that end, we have reviewed the emerging 
body of empirical literature in the field of what is increasingly 
referred to as socio-gerontechnology that explores ageing and 
technology as relational concepts across various domains, 
sites and scales.6 With the notion of co-constitution, we 
suggest that scholars avoid undue assumptions about ageing 
as a (more or less) fixed target for technological interventions, 
which is a tenet that underlies many conventional studies on 
ageing and technology.16 Rather, we suggest an approach that 
is attentive to the many ways in which the experience of ageing 
itself is constituted together with the increasing diffusion 
of technological innovations. So, our own studies in socio-
gerontechnology have shown how technological innovation 
creates ageing and older people as much as it targets them.17 
This is the case, for instance, when technology developers 
prioritize aspects of ageing that are easy to measure (such 
as the increased risk of falling), over those that are more 
difficult to grasp (such as social connectedness). Techological 
innovation then enacts older people as fallers, as much as it 
addresses the alleged risks of falling.18 The same is true for the 
life worlds of older people, where established values such as 
privacy or health are re-negotiated in interaction with newly 
introduced technologies, such as monitoring devices or a new 
medicine.19,20
In conclusion, therefore, I would like to suggest that 
further research into health innovation and health systems 
acknowledges the co-constitution of health systems and 
innovation. This will require doing away with the analytical 
separation between innovations and social context, to 
give way to an agenda for responsible innovation in health 
that is more attentive to the mutual shaping of innovations 
and health systems. As a most immediate consequence, it 
may be necessary to abond the widespread interventionist 
vocabulary that haunts current debates around ageing, health 
and technology, and that is expressed in terms like “impact,” 
“solution,” or “acceptance.” For sure, these terms have their 
merits in highlighting the relevance of thinking about the 
user side of health innovations. But they also assume, in one 
way or another, that there are stable and measurable effects 
of technologies on the lives of people and patients, or on 
the values and practices of health systems more broadly. A 
vocabulary that takes co-constitution to heart would rather 
put the evolving and generative entanglements of technologies 
with the values and practices of health systems center stage. 
As an empirical agenda, it allows us to study how such values 
and practices are constituted in relation to new technologies, 
rather than measuring an alleged impact on a pre-existing set 
of values and practices. This way, more nuanced approaches 
to responsible innovation in health will also become possible 
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that are sensitive to the changing identities of both health 
systems and technologies as they evolve in relation to each 
other. 
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Endnote
[1] To be sure, the lead author of the commented paper has pointed out the 
relevance of STS for understanding health innovation herself.8
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